Evaluation & Continuing education request form

A Fat Lib Look at GLP-1 Weight Loss Medications

Use this form to provide feedback on this event and/or if you are requesting a CDR certificate of completion or a certificate of attendance for other credentialing organizations. Please allow 5 business days to process CE certificates and certificates of attendance.

Continuing Education Credit Options

The CPE activity for this event is approved for 4.5 CPEUs. We can also prepare a certificate of attendance to support submissions to other accrediting bodies. Note: Check your credentialing organization to see if they accept pre-approved CDR continuing education credits.

Session Evaluation & Continuing Education Certificate Request Form

Did you attend the live session, watch the recording, or both? *

I attended the live session.
I watched the recording.
I did both.

Are you requesting a continuing education certificate of completion/attendance? (CEs are only available to the Professional Membership tier) *

I am requesting a certificate of completion for CDR pre-approved credits.
I am requesting a certificate of attendance to support my individual submission for continuing education credits.
I am not requesting a CE certificate.

Which statement most accurately summarizes the research on GLP-1 medications for weight loss? *

a. GLP-1 medications for weight loss induce an average weight loss of up to 22kg in the first year and prevent common diseases associated with higher weights.
b. GLP-1 medications for weight loss induce an average weight loss of up to 22kg, with weight loss most commonly plateauing after 1 year. Weight maintenance has been shown for an additional year after weight loss while continuing the medication.
c. GLP-1 medications for weight loss induce an average weight loss of up to 22kg with weight loss most commonly plateauing after 1 year. Weight maintenance is sustained for life as long as the medication is continued.

Which of the following are a limitation of the current research on GLP-1 medications for weight loss (select all that apply): *

a. Studies have not included a placebo group
b. Studies have not followed patients for more than 2-3 years
c. Studies have not included common, known confounders in weight and health
d. Studies have not reported results disaggregated by BMI or health status

It is ethical to pressure patients to take a GLP-1 medication for weight loss. *

True
False

Weight loss is one safe and effective way fat people can improve their health outcomes. *

Strongly Disagree
Disagree
Agree
Strongly Agree

The role of a healthcare provider is to (select all that apply): *

Help people get healthy.
Provide health information with patient consent.
Support patient-centered health goals.
Help people lose weight.

As a result of this session, what actionable steps will you make professionally or personally? *

Do you have any other last comments or thoughts to share with the ASDAH Leadership Team?